Lisata Therapeutics, Inc.
LSTA
$1.09
-$0.04-3.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.93M | -4.49M | -2.95M | -4.25M | -4.66M |
| Total Depreciation and Amortization | 3.00K | 2.00K | 15.00K | 44.00K | 44.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 214.00K | 364.00K | 852.00K | 218.00K | 219.00K |
| Change in Net Operating Assets | 63.00K | 1.04M | -1.16M | 645.00K | 440.00K |
| Cash from Operations | -2.65M | -3.08M | -3.25M | -3.34M | -3.96M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 5.15M | 505.00K |
| Cash from Investing | -- | -- | 0.00 | 5.15M | 505.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 29.00K | 340.00K | 205.00K | 353.00K | 74.00K |
| Repurchase of Common Stock | 0.00 | -159.00K | 0.00 | 0.00 | -10.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.00K | 181.00K | 205.00K | 353.00K | 64.00K |
| Foreign Exchange rate Adjustments | 3.00K | 6.00K | 2.00K | 2.00K | 5.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.62M | -2.90M | -3.04M | 2.16M | -3.38M |